Visit COVID-19 resources

[Skip to Content]

Variability of disease activity in patients treated with ranibizumab for neovascular age-related macular degeneration – (Eye Journal AOP)

20 May 2016

This news item is available to RCOphth members only, please log in below to access.

Members Login